AR

Anshika Rajput

Active Director Director DIN 08992828
DIN 08992828 First appointment Dec 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value •••• Premium profile

About Anshika Rajput

Data last updated:

Anshika Rajput is a Director at Neplar Pharmaceutical Private Limited (since 2020). The company operates in Pharma. Neplar Pharmaceutical Private Limited reported revenue of ₹1.7 Lakh (FY 2023).

DIN 08992828
Primary Designation Director
Industry Pharma
First Appointment 11 Dec 2020
Oldest Company Age 8 yrs
Largest company Neplar Pharmaceutical Private Limited · ₹1.7 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Dec 20202018₹1.7 Lakh (FY 2023)Active

Board colleagues of Anshika Rajput

NameDINCompanyDesignation
Navneet Kumar Rana08241514Neplar Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Neplar Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Anshika Rajput

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anshika Rajput

Anshika Rajput currently holds 1 directorship: Neplar Pharmaceutical Private Limited (Director, since 11 Dec 2020, revenue ₹1.7 Lakh (FY 2023)).

Anshika Rajput was first appointed on 11 Dec 2020 as Director at Neplar Pharmaceutical Private Limited.

The current boards of Anshika Rajput's companies include Navneet Kumar Rana (Neplar Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available